Demand of Life Cycle Management Industry : Technology, Applications, Growth and Status 2017

Albany, New York, August 31, 2017 : Recent research and the current scenario as well as future market potential of "Life Cycle Management Strategies - Optimizing revenues and defending generic competition" globally.

GBI Research’s latest report, ""Life Cycle Management Strategies Optimizing revenues and defending generic competition"" discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies, and keys to successful implementation of the strategies. The report provides detailed case studies for each of the key strategies such as indication expansion, reformulation, fixed-dose combinations, pricing strategies and so on.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=322850

Companies mentioned in the report are AbbVie, Actavis, AstraZeneca, Cipla, Gilead, GlaxoSmithKline, Gleevec, Janssen, MannKind, Merck, Novartis, Orexo, Otsuka, Pfizer, Roche, Salix Pharmaceuticals, Sanofi-Aventis, Solvay, Teva and Vifor Pharma.

Scope

Introduction of LCM and product life cycle
Objectives of LCM and factors impacting the choice of strategies
LCM strategies depending on the way of approach
Impact of LCM strategies on sales and growth trend of selected products
Patent term extension and market exclusivity in the US and Europe
LCM strategies of pipeline drugs of key players
Keys to successful implementation of LCM strategies

Reasons to buy

Identify the key LCM strategies used by most of the pharmaceutical companies
Analyze the strategies to increase lifecycle and revenues of a drug
Gain an understanding on the implementation of multiple strategies for a single product by including case studies
Understand the operational pipeline strategies of key players

Make an Enquiry about TOC @ http://www.researchmoz.us/enquiry.php?type=E&repid=322850

Executive Summary

Introduction
Overview of Product Life Cycle
Product Life Cycle Curve
Objectives of Life Cycle Management (LCM)
Classification and Benefits of LCM Strategies
Strategic Planning for LCM
Factors Impacting Choice of LCM Strategies
Developmental Strategies
Indication Expansion/Sequencing and Repositioning
Patient Subpopulations and Personalized Medicine
Reformulation
New Dosage Forms
New Route of Administration
Special Cases
New Dosage Strengths and Regimen
Fixed-Dose Combination and Co-packaging
Next Generation Products and Modified Chemistry
Metabolites
Chiral Switching
Polymorphs
Multiple Developmental Strategy Approach
Commercial Strategies
Rx-to-OTC/BTC Switch
Geographical Expansion
Pricing Strategy and Tactics
Pricing Strategy for Targeting Multiple Indications
Coupons
Co-pay Cards

Browse Report @ http://www.researchmoz.us/life-cycle-management-strategies-optimizing-revenues-and-defending-generic-competition-report.html

Awareness, Brand Loyalty and Service Programs
Regulatory and Legal Strategies
Authorized Generics
Legal Defense and Pay for Delay
Citizen’s Petition
Patent Term Extension and Market Exclusivity
The Pharmaceutical Pipeline and LCM
Successful Implementation of LCM Strategies

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

This release was published on openPR.